Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA approval
Pharma
Kedrion wins FDA nod for immunodeficiency disorder treatment
Italian plasma specialist Kedrion has scored an FDA approval for Qivigy, a treatment for a adults with primary humoral immunodeficiency.
Kevin Dunleavy
Sep 29, 2025 11:39am
Crinetics breaks commercial barrier with Palsonify FDA nod
Sep 25, 2025 5:30pm
Eli Lilly's oral SERD Inluriyo crosses FDA finish line
Sep 25, 2025 3:35pm
J&J pads Tremfya IBD offerings with subQ ulcerative colitis nod
Sep 22, 2025 11:01am
Merck scores FDA approval for subcutaneous Keytruda
Sep 19, 2025 4:54pm
FDA approves Corstasis' nasal spray as treatment for edema
Sep 15, 2025 3:33pm
